iPath Return on Disability ETN
RODI
RODI was delisted on the 20th of December, 2022.
2 hedge funds and large institutions have $0 invested in iPath Return on Disability ETN in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less capital invested
Capital invested by funds: $33.2M → $0 (-$33.2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$33.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| – | -$33.2M | -500,000 | Closed |
|
RODI Hedge Fund Activity: Q4 2017 in Review
2 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in iPath Return on Disability ETN (RODI) for Q4 2017, worth a combined $0 — down 100% from $33.2M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RODI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Barclays, exiting entirely with an estimated $33.2M sold.
- 2 institutional investors held iPath Return on Disability ETN (RODI) as of Q4 2017, down from 3 in Q3 2017.
- Funds reported $0 of iPath Return on Disability ETN stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new iPath Return on Disability ETN positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest iPath Return on Disability ETN seller in Q4 2017 was Barclays, an estimated $33.2M sold.
Based on aggregated 13F filings for Q4 2017.